Evidence-based clinical practice guidelines for inflammatory bowel disease 2020

H Nakase, M Uchino, S Shinzaki, M Matsuura… - Journal of …, 2021 - Springer
Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing
inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

Management of paediatric ulcerative colitis, part 1: ambulatory care—an evidence-based guideline from European Crohn's and Colitis Organization and European …

D Turner, FM Ruemmele… - Journal of pediatric …, 2018 - journals.lww.com
Background: The contemporary management of ambulatory ulcerative colitis (UC) continues
to be challenging with∼ 20% of children needing a colectomy within childhood years. We …

An update on current pharmacotherapeutic options for the treatment of ulcerative colitis

F Ferretti, R Cannatelli, MC Monico, G Maconi… - Journal of Clinical …, 2022 - mdpi.com
The main goals of Ulcerative Colitis (UC) treatment are to both induce and maintain the
clinical and endoscopic remission of disease, reduce the incidence of complications such as …

Natural compounds as safe therapeutic options for ulcerative colitis

M Gupta, V Mishra, M Gulati, B Kapoor, A Kaur… - …, 2022 - Springer
Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology. Several
conventional treatments for UC such as corticosteroids, immunosuppressive agents, tumor …

Three acidic polysaccharides derived from sour jujube seeds protect intestinal epithelial barrier function in LPS induced Caco-2 cell inflammation model

Y Liu, Y Zhang, N Mei, W Li, T Yang, J Xie - International Journal of …, 2023 - Elsevier
Normal intestinal epithelial barrier function plays a key role in the prevention of many
diseases such as infectious enteritis, inflammatory bowel disease, obesity, etc. In this study …

Guía GETECCU 2020 para el tratamiento de la colitis ulcerosa. Elaborada con metodología GRADE

B Sicilia, S García-López, Y González-Lama… - Gastroenterología y …, 2020 - Elsevier
Introducción Desde la publicación de la primera edición de la Guía en 2013, se ha
generado mucha información en torno al tratamiento de la colitis ulcerosa, y se han …

Inflammatory Bowel Disease in Japan-Is It Similar to or Different from Westerns?-

S Okabayashi, T Kobayashi, T Hibi - … of the anus, Rectum and colon, 2020 - jstage.jst.go.jp
Ulcerative colitis and Crohn's disease, the most common types of inflammatory bowel
disease, are idiopathic, intractable disease characterized by chronic inflammation in the …